Radiopharmaceuticals in the Treatment of Metastatic Castration-Resistant Prostate Cancer
CCO Oncology Podcast - Podcast autorstwa Clinical Care Options
Kategorie:
In this podcast episode, listen to Chris Parker, MD, and Bertrand Tombal, MD, PhD, as they discuss clinical implications of the latest data from ASCO 2021 on using radium-223, PSMA lutetium, and bone health approaches for the treatment and management of patients with metastatic castration-resistant prostate cancer.
